collection
https://read.qxmd.com/read/30653672/british-association-of-dermatologists-guidelines-for-the-safe-and-effective-prescribing-of-oral-ciclosporin-in-dermatology-2018
#1
JOURNAL ARTICLE
J Berth-Jones, L S Exton, E Ladoyanni, M F Mohd Mustapa, V M Tebbs, P D Yesudian, N J Levell
No abstract text is available yet for this article.
June 2019: British Journal of Dermatology
https://read.qxmd.com/read/30447971/-no-actually-it-is-not-a-headache
#2
JOURNAL ARTICLE
Jules Morgan
No abstract text is available yet for this article.
February 2020: Lancet Neurology
https://read.qxmd.com/read/30582516/one-year-in-review-2018-beh%C3%A3-et-s-syndrome
#3
REVIEW
Gulen Hatemi, Emire Seyahi, Izzet Fresko, Rosaria Talarico, Vedat Hamuryudan
New epidemiologic studies from Poland, Jordan, Algeria, Taiwan and Korea highlight the geographic differences in incidence, prevalence and clinical features of Behçet's syndrome (BS). A study from Austria comparing clinical manifestations of their BS patients with different countries of origin suggest that environmental factors may be important in the disease phenotype of BS. New genetic association studies dealing with the innate and acquired aspects of BS prevailed during 2017 and novel susceptibility and regulatory factors were described...
2018: Clinical and Experimental Rheumatology
https://read.qxmd.com/read/30541875/heartbeat-heart-failure-induced-by-cancer-therapy
#4
JOURNAL ARTICLE
Catherine M Otto
No abstract text is available yet for this article.
January 2019: Heart
https://read.qxmd.com/read/30499630/how-i-investigate-eosinophilia
#5
REVIEW
Rebecca L Larsen, Natasha M Savage
Eosinophilia is typically secondary, that is, reactive, in nature and is associated with a wide variety of neoplastic and non-neoplastic disorders. Clonal eosinophilia is also seen in a wide variety of hematopoietic neoplasms, and sub-classification can be diagnostically challenging. A proper evaluation of persistent eosinophilia involves correlation of clinical history, laboratory data, cellular morphology, and ancillary testing. Knowledge of appropriate ancillary testing is necessary for a timely diagnosis...
April 2019: International Journal of Laboratory Hematology
https://read.qxmd.com/read/30415610/low-dose-methotrexate-for-the-prevention-of-atherosclerotic-events
#6
RANDOMIZED CONTROLLED TRIAL
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga, Milan Gupta, Michelle Tsigoulis, Subodh Verma, Michael Clearfield, Peter Libby, Samuel Z Goldhaber, Roger Seagle, Cyril Ofori, Mohammad Saklayen, Samuel Butman, Narendra Singh, Michel Le May, Olivier Bertrand, James Johnston, Nina P Paynter, Robert J Glynn
BACKGROUND: Inflammation is causally related to atherothrombosis. Treatment with canakinumab, a monoclonal antibody that inhibits inflammation by neutralizing interleukin-1β, resulted in a lower rate of cardiovascular events than placebo in a previous randomized trial. We sought to determine whether an alternative approach to inflammation inhibition with low-dose methotrexate might provide similar benefit. METHODS: We conducted a randomized, double-blind trial of low-dose methotrexate (at a target dose of 15 to 20 mg weekly) or matching placebo in 4786 patients with previous myocardial infarction or multivessel coronary disease who additionally had either type 2 diabetes or the metabolic syndrome...
February 21, 2019: New England Journal of Medicine
https://read.qxmd.com/read/30376041/antimicrobial-approaches-in-the-prevention-of-staphylococcus-aureus-infections-a-review
#7
JOURNAL ARTICLE
D P R Troeman, D Van Hout, J A J W Kluytmans
Background: The prophylactic application of antimicrobials that are active against Staphylococcus aureus can prevent infections. However, implementation in clinical practice is limited. We have reviewed antimicrobial approaches for the prevention of S. aureus infections. Methods: We searched the Cochrane Central Register of Controlled Trials, PubMed/MEDLINE and EMBASE databases and trial registries using synonyms for S. aureus, infections and prevention as search terms...
February 1, 2019: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/30418557/sequential-intravenous-to-oral-outpatient-antibiotic-therapy-for-mrsa-bacteraemia-one-step-closer
#8
JOURNAL ARTICLE
Sarah C J Jorgensen, Abdalhamid M Lagnf, Sahil Bhatia, Muhammad-Daniayl Shamim, Michael J Rybak
Background: Published guidelines call for prolonged courses of intravenous (iv) antibiotics for the treatment of MRSA bloodstream infection (BSI) to ensure eradication of deep foci and decrease relapse risk. Sequential iv-to-oral antibiotic therapy has been successfully applied to other serious infections but has not been evaluated for MRSA BSI. Objectives: To compare outcomes in adults completing MRSA BSI therapy with oral versus parenteral antibiotics in the outpatient setting [oral outpatient antibiotic therapy (OOAT) versus outpatient parenteral antibiotic therapy (OPAT)]...
February 1, 2019: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/30547302/the-role-of-vitamins-and-minerals-in-hair-loss-a-review
#9
REVIEW
Hind M Almohanna, Azhar A Ahmed, John P Tsatalis, Antonella Tosti
People commonly inquire about vitamin and mineral supplementation and diet as a means to prevent or manage dermatological diseases and, in particular, hair loss. Answering these queries is frequently challenging, given the enormous and conflicting evidence that exists on this subject. There are several reasons to suspect a role for micronutrients in non-scarring alopecia. Micronutrients are major elements in the normal hair follicle cycle, playing a role in cellular turnover, a frequent occurrence in the matrix cells in the follicle bulb that are rapidly dividing...
December 13, 2018: Dermatology and Therapy
https://read.qxmd.com/read/30545359/glp-1ras-in-type-2-diabetes-mechanisms-that-underlie-cardiovascular-effects-and-overview-of-cardiovascular-outcome-data
#10
REVIEW
Andrei C Sposito, Otávio Berwanger, Luiz Sérgio F de Carvalho, José Francisco Kerr Saraiva
Patients with type 2 diabetes (T2DM) have a substantial risk of developing cardiovascular disease. The strong connection between the severity of hyperglycaemia, metabolic changes secondary to T2DM and vascular damage increases the risk of macrovascular complications. There is a challenging demand for the development of drugs that control hyperglycaemia and influence other metabolic risk factors to improve cardiovascular outcomes such as cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, hospitalization for unstable angina and heart failure (major adverse cardiovascular events)...
December 13, 2018: Cardiovascular Diabetology
https://read.qxmd.com/read/30480766/ezetimibe-for-the-prevention-of-cardiovascular-disease-and-all-cause-mortality-events
#11
JOURNAL ARTICLE
Shipeng Zhan, Min Tang, Fang Liu, Peiyuan Xia, Maoqin Shu, Xiaojiao Wu
BACKGROUND: Cardiovascular disease (CVD) remains an important cause of mortality and morbidity, and high levels of blood cholesterol are thought to be the major modifiable risk factors for CVD. The use of statins is the preferred treatment strategy for the prevention of CVD, but some people at high-risk for CVD are intolerant to statin therapy or unable to achieve their treatment goals with the maximal recommended doses of statin. Ezetimibe is a selective cholesterol absorption inhibitor, whether it has a positive effect on CVD events remains uncertain...
November 19, 2018: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/30552762/british-association-of-dermatologists-guidelines-for-the-management-of-hidradenitis-suppurativa-acne-inversa-2018
#12
JOURNAL ARTICLE
J R Ingram, F Collier, D Brown, T Burton, J Burton, M F Chin, N Desai, T E E Goodacre, V Piguet, A E Pink, L S Exton, M F Mohd Mustapa
No abstract text is available yet for this article.
May 2019: British Journal of Dermatology
https://read.qxmd.com/read/30535100/seven-versus-14-days-of-antibiotic-therapy-for-uncomplicated-gram-negative-bacteremia-a-noninferiority-randomized-controlled-trial
#13
RANDOMIZED CONTROLLED TRIAL
Dafna Yahav, Erica Franceschini, Fidi Koppel, Adi Turjeman, Tanya Babich, Roni Bitterman, Ami Neuberger, Nesrin Ghanem-Zoubi, Antonella Santoro, Noa Eliakim-Raz, Barak Pertzov, Tali Steinmetz, Anat Stern, Yaakov Dickstein, Elias Maroun, Hiba Zayyad, Jihad Bishara, Danny Alon, Yonatan Edel, Elad Goldberg, Claudia Venturelli, Cristina Mussini, Leonard Leibovici, Mical Paul
BACKGROUND: Gram-negative bacteremia is a major cause of morbidity and mortality in hospitalized patients. Data to guide the duration of antibiotic therapy are limited. METHODS: This was a randomized, multicenter, open-label, noninferiority trial. Inpatients with gram-negative bacteremia, who were afebrile and hemodynamically stable for at least 48 hours, were randomized to receive 7 days (intervention) or 14 days (control) of covering antibiotic therapy. Patients with uncontrolled focus of infection were excluded...
September 13, 2019: Clinical Infectious Diseases
https://read.qxmd.com/read/30115843/treatment-of-invasive-candidiasis-a-narrative-review
#14
REVIEW
Ronen Ben-Ami
Invasive candidiasis occurs frequently in hospitalized patients, and is associated with high mortality rates due to delays in recognition and initiation of appropriate antifungals. Management of invasive candidiasis must take into account multiple host, pathogen, and drug-related factors, including the site of infection, host immune status, severity of sepsis, resistance and tolerance to antifungal agents, biofilm formation, and pharmacokinetic/pharmacodynamic considerations. Recent treatment directives have been shaped by the widespread introduction of echinocandins, highly potent and safe antifungals, into clinical use, as well as important changes in drug susceptibility patterns and the emergence of known and novel drug-resistant Candida species...
August 16, 2018: Journal of Fungi (Basel, Switzerland)
https://read.qxmd.com/read/30496838/european-resuscitation-council-guidelines-for-resuscitation-2018-update-antiarrhythmic-drugs-for-cardiac-arrest
#15
JOURNAL ARTICLE
Jasmeet Soar, Gavin D Perkins, Ian Maconochie, Bernd W Böttiger, Charles D Deakin, Claudio Sandroni, Theresa M Olasveengen, Jonathan Wyllie, Robert Greif, Andrew Lockey, Federico Semeraro, Patrick Van de Voorde, Carsten Lott, Leo Bossaert, Koenraad G Monsieurs, Jerry P Nolan
This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR)...
January 2019: Resuscitation
https://read.qxmd.com/read/30528423/acute-lobar-atelectasis
#16
REVIEW
John J Marini
Lobar atelectasis (or collapse) is an exceedingly common, rather predictable, and potentially pathogenic companion to many forms of acute illness, postoperative care, and chronic debility. Readily diagnosed by using routine chest imaging and bedside ultrasound, the consequences from lobar collapse may be minor or serious, depending on extent, mechanism, patient vulnerability, abruptness of onset, effectiveness of hypoxic vasoconstriction, and compensatory reserves. Measures taken to reduce secretion burden, assure adequate secretion clearance, maintain upright positioning, reverse lung compression, and sustain lung expansion accord with a logical physiologic rationale...
May 2019: Chest
https://read.qxmd.com/read/30421699/south-african-dyslipidaemia-guideline-consensus-statement-2018-update-a-joint-statement-from-the-south-african-heart-association-sa-heart-and-the-lipid-and-atherosclerosis-society-of-southern-africa-lassa
#17
JOURNAL ARTICLE
E Klug, F J Raal, A D Marais, C M Smuts, C Schamroth, D Jankelow, D J Blom, D A Webb
South Africa (SA) is home to a heterogeneous population with a wide range of cardiovascular risk factors. Cholesterol reduction in combination with aggressive management of modifiable risk factors, including nutrition, physical activity, blood pressure and smoking, can help to reduce and prevent morbidity and mortality in individuals who are at increased risk of cardiovascular events. This updated consensus guide to management of dyslipidaemia in SA is based on the updated European Society of Cardiology and European Atherosclerosis Society dyslipidaemia guidelines published in 2016...
October 26, 2018: South African Medical Journal
https://read.qxmd.com/read/30484286/oral-isotretinoin-for-acne
#18
JOURNAL ARTICLE
Caroline S Costa, Ediléia Bagatin, Ana Luiza C Martimbianco, Edina Mk da Silva, Marília M Lúcio, Parker Magin, Rachel Riera
BACKGROUND: Acne vulgaris, a chronic inflammatory disease of the pilosebaceous unit associated with socialisation and mental health problems, may affect more than 80% of teenagers. Isotretinoin is the only drug that targets all primary causal factors of acne; however, it may cause adverse effects. OBJECTIVES: To assess efficacy and safety of oral isotretinoin for acne vulgaris. SEARCH METHODS: We searched the following databases up to July 2017: the Cochrane Skin Group Specialised Register, CENTRAL, MEDLINE, Embase, PsycINFO and LILACS...
November 24, 2018: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/30499702/exacerbation-of-copd
#19
JOURNAL ARTICLE
Suzanne Lareau, Erika Moseson, Christopher G Slatore
No abstract text is available yet for this article.
December 1, 2018: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/30531479/the-emerging-role-of-ketogenic-diets-in-cancer-treatment
#20
REVIEW
Rainer Johannes Klement
PURPOSE OF REVIEW: Altered glucose metabolism in cancer cells is an almost ubiquitous observation, yet hardly exploited therapeutically. However, ketogenic diets have gained growing attention in recent years as a nontoxic broad-spectrum approach to target this major metabolic difference between normal and cancer cells. Although much research still needs to be done, new knowledge has been gained about the optimal utilization of ketogenic diets for cancer treatment that this review aims to summarize...
March 2019: Current Opinion in Clinical Nutrition and Metabolic Care
label_collection
label_collection
11520
1
2
2018-12-14 13:04:24
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.